Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 304 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HPV Infections Clear all

Conditions: Human Papilloma Virus, Warts, Warts, Genital, Condyloma, Condylomata Acuminata
Interventions: nonavalent human papillomavirus vaccine; Biological
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV Infection
Interventions: Self-Collected HPV Test, Usual Care; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: HPV Infection, Preventive Health Services
Interventions: Physician Communication 2 Virtual (PCOM2-virtual), Physician Communication Standard (PCOM-standard); Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 9 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Aurora, Colorado • Wichita, Kansas

Conditions: Human Papillomavirus (HPV) Vaccines
Interventions: Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,296 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Myelokathexis, Infections, Neutropenia, Warts, Hypogammaglobulinemia
Interventions: Plerixafor, G-CSF; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 10 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Infections, Condyloma Acuminata
Interventions: Cidofovir; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 11
States / cities: Berkeley, California • San Francisco, California • Denver, Colorado + 6 more

Conditions: HPV Seroconversion
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 26 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Human Papillomavirus Infection
Interventions: Biomarker Analysis, Biospecimen Collection, Ultrasonography; Other · Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 50 Years to 64 Years · Male only
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Common Warts
Interventions: A-101 Solution 40, A-101 Solution 45, Vehicle Solution; Drug
Lead sponsor: Aclaris Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Wayne, Pennsylvania

Conditions: Oropharynx Cancer
Interventions: therapeutic conventional surgery, laboratory biomarker analysis, quality-of-life assessment, intensity-modulated radiation therapy, Cisplatin, Carboplatin; Procedure · Other · Radiation + 1 more
Lead sponsor: Heath Skinner; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy, Human Papilloma Virus Infection
Interventions: educational intervention; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 624 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Human Papilloma Virus, Vaccine-Preventable Diseases
Interventions: HPV Twitter Education Program - Narrative, HPV Twitter Education Program - Non-Narrative; Other
Lead sponsor: University of Arkansas, Fayetteville; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Uterine Cervical Neoplasms, Sexually Transmitted Diseases
Interventions: Not listed
Lead sponsor: Fenway Community Health; Other
Eligibility: 21 Years to 64 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HPV Infection, HPV Vaccine
Interventions: HPV vaccine; Biological
Lead sponsor: University of Washington; Other
Eligibility: 27 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms
Interventions: Assessment of Oral HPV Infection; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Actinic Keratosis, Acne/Rosacea, Verruca Plana, Tinea, Molluscum Contagiosum, Bowen's Disease, Warts
Interventions: Non-thermal, atmospheric plasma to treat skin lesions and acne, Indirect non-thermal, atmospheric plasma to treat hair loss and acne; Device
Lead sponsor: The Skin Center Dermatology Group; Industry
Eligibility: 4 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: New City, New York

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 34
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 26 more

Conditions: Common Warts (Verruca Vulgaris), Common Warts, Human Papilloma Virus (HPV), Warts
Interventions: Cantharidin; Combination Product
Lead sponsor: Verrica Pharmaceuticals Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 10
States / cities: Saint Augustine, Florida • Plainfield, Indiana • New Orleans, Louisiana + 7 more

Conditions: Common Warts, HPV (Human Papillomavirus), Periungual Warts, Plantar Warts
Interventions: Sensitizing DPCP Ointment, Treatment DPCP Ointment; Drug
Lead sponsor: RXi Pharmaceuticals, Corp.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 4
States / cities: Miami, Florida • Oakbrook Terrace, Illinois • Indianapolis, Indiana + 1 more

Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 1, Human Papilloma Virus Infection
Interventions: placebo, defined green tea catechin extract, laboratory biomarker analysis; Drug · Dietary Supplement · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Human Papillomavirus Infection
Interventions: Quadrivalent human papillomavirus vaccine on-time administration, Quadrivalent human papillomavirus vaccine delayed administration; Biological
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 23 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Human Papillomavirus Infection
Interventions: Not listed
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Vaccine Preventable Diseases, Meningococcal Disease, Human Papillomavirus, Pertussis, Influenza
Interventions: Point-of-Care Prompt; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 11 Years to 18 Years
Enrollment: 7,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 22
States / cities: Little Rock, Arkansas • Wilmington, Delaware • Gainesville, Florida + 12 more

Conditions: Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts
Interventions: VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan); Combination Product
Lead sponsor: Verrica Pharmaceuticals Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 12
States / cities: San Diego, California • Jacksonville, Florida • Sweetwater, Florida + 9 more

Search by objective public record fields.

Intralesional HPV Vaccine for Condylomata

The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling

PCOM2 - The Physician Communication Intervention, Version 2.0

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients

Gardasil Immunogenicity With Needle-Free Injection

Throat and Other HPV-Related Cancers in Men: Identifying Them Early

A Study of A-101 Solution in Subjects With Common Warts.

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

The Parents in Appalachia Receive Education Needed for Teen Project

Hashtag HPV: HPV Vaccine Twitter Education Program

Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients

Intradermal, Fractional Dose of HPV Vaccines:

Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting

The Human Papillomavirus (HPV) Transmission Pilot Study

Testing the Use of Prompts to Increase Adolescent Immunization Rates

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)